GlassScriptPhysician profile
Joud G Dib
NPI 1033273628
$837.37
in general payments reported to CMS, 2019-2025
8 companies · $76.85 in 2025
The $76.85 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.07 · 2021: $337 · 2022: $227 · 2023: $112 · 2024: $63.59 · 2025: $76.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $532.77 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $148.17 | 2023-2025 | Watchman Access System, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Inari Medical, INC. | $47.95 | 2022 | |
| Abbott Laboratories | $42.42 | 2022-2024 | Esprit |
| Medtronic Vascular, INC. | $21.07 | 2020 | |
| Cardiovascular Systems INC. | $19.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.84 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joud Dib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.